Hypertension Management with Thiazide Diuretics

Introduction to Thiazide Diuretics

Thiazide diuretics are indicated as first-line therapy for most patients with uncomplicated hypertension, especially in stage 1 hypertension, and should be included in most combination regimens for stage 2 hypertension, as recommended by the American College of Cardiology with strong evidence 1
The American College of Cardiology recommends thiazide diuretics as one of three first-line agents (along with ACEIs/ARBs and CCBs) for initial treatment of hypertension, with strong evidence 1
The 2017 ACC/AHA guidelines specifically endorse thiazide diuretics as first-line agents with strong evidence 1

Black patients: Thiazide diuretics or calcium channel blockers are preferred over ACEIs/ARBs as initial therapy, according to the American Heart Association 2, 1
Black patients are more likely to respond to thiazide diuretics than ACEIs, with superior blood pressure control 2, 1

Stage 1 hypertension: Thiazide diuretics can be used as monotherapy with dose titration, as recommended by the American College of Cardiology 1
Stage 2 hypertension: Thiazide diuretics should be part of initial combination therapy, typically with an ACEI/ARB, according to the American College of Cardiology 1

Thiazide diuretics are indicated in combination regimens when blood pressure remains uncontrolled on monotherapy, with the addition of a second agent such as an ACEI/ARB or CCB 2
Thiazide diuretics should be used as part of initial two-drug combination therapy for stage 2 hypertension (BP >20/10 mmHg above target), as recommended by the American College of Cardiology 1
Thiazide diuretics are almost universally included in triple therapy combinations (CCB + thiazide + ACEI/ARB), according to the American Heart Association 3, 2

Chlorthalidone may be preferred over hydrochlorothiazide due to its longer half-life, more consistent 24-hour blood pressure control, and better cardiovascular outcomes data, as reported by the American College of Cardiology 4
Low-dose therapy (12.5-25mg hydrochlorothiazide equivalent) is recommended to minimize metabolic side effects while maintaining efficacy, according to the American Heart Association 5, 3

Initial dose: Start with low dose (12.5mg hydrochlorothiazide or 6.25mg chlorthalidone) and titrate to effective dose (maximum 25-50mg hydrochlorothiazide or 25mg chlorthalidone) 5
Inadequate response: If BP target not achieved after 2-4 weeks, add second agent (ACEI/ARB or CCB), as recommended by the American College of Cardiology 3
Monitoring: Check electrolytes (especially potassium and magnesium) within 2-4 weeks of initiation, and monitor glucose and lipid profiles periodically, according to the American Heart Association 5